96 related articles for article (PubMed ID: 15221962)
1. Intratumor chromosomal heterogeneity in advanced carcinomas of the uterine cervix.
Lyng H; Beigi M; Svendsrud DH; Brustugun OT; Stokke T; Kristensen GB; Sundfør K; Skjønsberg A; De Angelis PM
Int J Cancer; 2004 Sep; 111(3):358-66. PubMed ID: 15221962
[TBL] [Abstract][Full Text] [Related]
2. Advanced-stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q.
Heselmeyer K; Macville M; Schröck E; Blegen H; Hellström AC; Shah K; Auer G; Ried T
Genes Chromosomes Cancer; 1997 Aug; 19(4):233-40. PubMed ID: 9258658
[TBL] [Abstract][Full Text] [Related]
3. Comparative genomic hybridization reveals a recurrent pattern of chromosomal aberrations in severe dysplasia/carcinoma in situ of the cervix and in advanced-stage cervical carcinoma.
Kirchhoff M; Rose H; Petersen BL; Maahr J; Gerdes T; Lundsteen C; Bryndorf T; Kryger-Baggesen N; Christensen L; Engelholm SA; Philip J
Genes Chromosomes Cancer; 1999 Feb; 24(2):144-50. PubMed ID: 9885981
[TBL] [Abstract][Full Text] [Related]
4. Genomic changes and HPV type in cervical carcinoma.
Matthews CP; Shera KA; McDougall JK
Proc Soc Exp Biol Med; 2000 Mar; 223(3):316-21. PubMed ID: 10719846
[TBL] [Abstract][Full Text] [Related]
5. Genomic aberrations in carcinomas of the uterine corpus.
Micci F; Teixeira MR; Haugom L; Kristensen G; Abeler VM; Heim S
Genes Chromosomes Cancer; 2004 Jul; 40(3):229-46. PubMed ID: 15139002
[TBL] [Abstract][Full Text] [Related]
6. Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status.
Mullokandov MR; Kholodilov NG; Atkin NB; Burk RD; Johnson AB; Klinger HP
Cancer Res; 1996 Jan; 56(1):197-205. PubMed ID: 8548763
[TBL] [Abstract][Full Text] [Related]
7. Detection of chromosomal alterations in bladder transitional cell carcinomas from Northern China by comparative genomic hybridization.
Qin SL; Chen XJ; Xu X; Shou JZ; Bi XG; Ji L; Han YL; Cai Y; Wei F; Ma JH; Wu M; Zhan QM; Wang MR
Cancer Lett; 2006 Jul; 238(2):230-9. PubMed ID: 16125302
[TBL] [Abstract][Full Text] [Related]
8. Integrated genomic and transcriptional profiling identifies chromosomal loci with altered gene expression in cervical cancer.
Wilting SM; de Wilde J; Meijer CJ; Berkhof J; Yi Y; van Wieringen WN; Braakhuis BJ; Meijer GA; Ylstra B; Snijders PJ; Steenbergen RD
Genes Chromosomes Cancer; 2008 Oct; 47(10):890-905. PubMed ID: 18618715
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of genomic alterations in invasive cervical squamous cell carcinoma of clinical stage IB detected by comparative genomic hybridization.
Dellas A; Torhorst J; Jiang F; Proffitt J; Schultheiss E; Holzgreve W; Sauter G; Mihatsch MJ; Moch H
Cancer Res; 1999 Jul; 59(14):3475-9. PubMed ID: 10416613
[TBL] [Abstract][Full Text] [Related]
10. Genetic abnormalities and HPV status in cervical and vulvar squamous cell carcinomas.
Huang FY; Kwok YK; Lau ET; Tang MH; Ng TY; Ngan HY
Cancer Genet Cytogenet; 2005 Feb; 157(1):42-8. PubMed ID: 15676146
[TBL] [Abstract][Full Text] [Related]
11. Chromosomal aberrations by comparative genomic hybridization in hürthle cell thyroid carcinomas are associated with tumor recurrence.
Wada N; Duh QY; Miura D; Brunaud L; Wong MG; Clark OH
J Clin Endocrinol Metab; 2002 Oct; 87(10):4595-601. PubMed ID: 12364440
[TBL] [Abstract][Full Text] [Related]
12. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.
Redon R; Muller D; Caulee K; Wanherdrick K; Abecassis J; du Manoir S
Cancer Res; 2001 May; 61(10):4122-9. PubMed ID: 11358835
[TBL] [Abstract][Full Text] [Related]
13. Chromosomal gains and losses in primary colorectal carcinomas detected by CGH and their associations with tumour DNA ploidy, genotypes and phenotypes.
De Angelis PM; Clausen OP; Schjølberg A; Stokke T
Br J Cancer; 1999 May; 80(3-4):526-35. PubMed ID: 10408863
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive molecular cytogenetic characterization of cervical cancer cell lines.
Harris CP; Lu XY; Narayan G; Singh B; Murty VV; Rao PH
Genes Chromosomes Cancer; 2003 Mar; 36(3):233-41. PubMed ID: 12557223
[TBL] [Abstract][Full Text] [Related]
15. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix.
Heselmeyer K; Schröck E; du Manoir S; Blegen H; Shah K; Steinbeck R; Auer G; Ried T
Proc Natl Acad Sci U S A; 1996 Jan; 93(1):479-84. PubMed ID: 8552665
[TBL] [Abstract][Full Text] [Related]
16. PCC and COBRA-FISH a new tool to characterize primary cervical carcinomas: to assess hall-marks and stage specificity.
Darroudi F; Bergs JW; Bezrookove V; Buist MR; Stalpers LJ; Franken NA
Cancer Lett; 2010 Jan; 287(1):67-74. PubMed ID: 19553004
[TBL] [Abstract][Full Text] [Related]
17. Genetic heterogeneity by comparative genomic hybridization in BRCAx breast cancers.
Mangia A; Chiarappa P; Tommasi S; Chiriatti A; Petroni S; Schittulli F; Paradiso A
Cancer Genet Cytogenet; 2008 Apr; 182(2):75-83. PubMed ID: 18406868
[TBL] [Abstract][Full Text] [Related]
18. Comparative genomic hybridization analysis detects frequent, often high-level, overrepresentation of DNA sequences at 3q, 5p, 7p, and 8q in human non-small cell lung carcinomas.
Balsara BR; Sonoda G; du Manoir S; Siegfried JM; Gabrielson E; Testa JR
Cancer Res; 1997 Jun; 57(11):2116-20. PubMed ID: 9187106
[TBL] [Abstract][Full Text] [Related]
19. Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix.
Wilting SM; Snijders PJ; Meijer GA; Ylstra B; van den Ijssel PR; Snijders AM; Albertson DG; Coffa J; Schouten JP; van de Wiel MA; Meijer CJ; Steenbergen RD
J Pathol; 2006 Jun; 209(2):220-30. PubMed ID: 16538612
[TBL] [Abstract][Full Text] [Related]
20. Genetic alterations in cervical carcinomas: frequent low-level amplifications of oncogenes are associated with human papillomavirus infection.
Zhang A; Månér S; Betz R; Angström T; Stendahl U; Bergman F; Zetterberg A; Wallin KL
Int J Cancer; 2002 Oct; 101(5):427-33. PubMed ID: 12216070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
